Triflusal

Chemical formula: C₁₀H₇F₃O₄  Molecular mass: 248.157 g/mol  PubChem compound: 9458

Therapeutic indications

Triflusal is indicated for:

Secondary prophylaxis of myocardial infarction, angina

Population group: only adults (18 years old or older)

Secondary prophylaxis, after a first coronary ischaemic event, of:

  • Myocardial infarction.
  • Stable or unstable angina.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Secondary prophylaxis of cerebrovascular ischaemic event

Population group: only adults (18 years old or older)

Secondary prophylaxis, after a first cerebrovascular ischaemic event, of transient or permanent non-haemorrhagic cerebrovascular accident.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Triflusal is contraindicated in the following cases:

Bleeding

Bleeding

Peptic ulcer

at least one of
Peptic ulcer
H/O: peptic ulcer

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) : TRIFLUSAL Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈